Patient safety in medical research is a paramount concern that underscores the ethical framework guiding clinical trials and studies.As more than $2 billion in federal research grants face cutbacks, the integrity of research participant protection is jeopardized, hampering the vital oversight mandated by institutional review boards (IRBs).